Actavis, Inc. News Headlines

ACT 
$288.08
*  
1.73
0.6%
Get ACT Alerts
*Delayed - data as of May 5, 2015 10:40 ET  -  Find a broker to begin trading ACT now
Exchange: NYSE
Industry: Health Care
Community Rating:
View:    ACT Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By





Pershing Square Benefits from Allergan Takeover Deal
4/6/2015 7:06:00 PM - Market Realist
















How Actavis Generics Drive Revenues
4/3/2015 3:06:00 PM - Market Realist












US Financials Throng the High-Grade Bond Market
4/2/2015 6:06:00 PM - Market Realist




North American Brands’s Position of Strength
4/2/2015 1:06:00 PM - Market Realist






3 Key Therapeutic Segments Drive Branded Revenues
4/1/2015 8:05:00 PM - Market Realist


How Actavis Organizes Its Business
4/1/2015 7:06:00 PM - Market Realist